Basal Cell Carcinoma (BCC) Recruiting Phase 1 / 2 Trials for Pembrolizumab (DB09037)

Also known as: BCC - Basal Cell Carcinoma / Basal Cell Carcinomas / Basal Cell Carcinoma / Carcinoma basal cell / Basalioma / Basal cell epithelioma / Rodent ulcer / Basal cell carcinoma (morphologic abnormality) / Basal cell carcinoma of skin (disorder) / Carcinoma, Basal Cell

IndicationStatusPhase
DBCOND0040396 (Basal Cell Carcinoma (BCC))Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05086692A Beta-only IL-2 ImmunoTherapY StudyTreatment